Ligand-mediated delivery of RNAi-based therapeutics for the treatment of oncological diseases

RNA interference (RNAi)-based therapeutics (miRNAs, siRNAs) have great potential for treating various human diseases through their ability to downregulate proteins associated with disease progression. However, the development of RNAi-based therapeutics is limited by lack of safe and specific deliver...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelaal, Ahmed M, Kasinski, Andrea L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Critical Reviews and Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291076/
https://www.ncbi.nlm.nih.gov/pubmed/34316717
http://dx.doi.org/10.1093/narcan/zcab030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291076/
https://www.ncbi.nlm.nih.gov/pubmed/34316717
http://dx.doi.org/10.1093/narcan/zcab030

Ejemplares similares